azauridine has been researched along with acyclovir in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 12 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Boido, V; Collu, G; Fermeglia, M; Ibba, C; La Colla, P; Loddo, R; Paneni, MS; Posocco, P; Pricl, S; Secci, B; Sparatore, F; Tasso, B; Tonelli, M; Vazzana, I | 1 |
Blois, S; Boido, V; Giliberti, G; Ibba, C; La Colla, P; Loddo, R; Novelli, F; Paglietti, G; Pricl, S; Sanna, G; Simone, M; Sparatore, F; Tasso, B; Tonelli, M | 1 |
Blois, S; Boatto, G; Briguglio, I; Busonera, B; Carta, A; Corona, P; Giliberti, G; Giunchedi, P; Ibba, C; Iuliano, F; La Colla, P; Marongiu, ME; Nieddu, M; Piras, S | 1 |
Carta, A; Corona, P; Farci, P; Giliberti, G; La Colla, P; Loriga, M; Marongiu, ME; Paglietti, G; Sanna, G; Vitale, G | 1 |
Briguglio, I; Carta, A; Corona, P; Farci, P; Giliberti, G; Ibba, C; La Colla, P; Loddo, R; Loriga, M; Paglietti, G; Piras, S; Sanna, G | 1 |
Boido, V; Busonera, B; Farci, P; Giliberti, G; Ibba, C; La Colla, P; Loddo, R; Novelli, F; Sanna, G; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M; Vazzana, I | 1 |
Atzori, EM; Biava, M; Collu, G; Delogu, I; Desideri, N; Droghini, P; Fioravanti, R; Ibba, C; Loddo, R; Sanna, G | 1 |
Augustynowicz-Kopeć, E; Bielenica, A; Boi, S; Giliberti, G; Madeddu, S; Napiórkowska, A; Sanna, G; Stefańska, J; Stępień, K; Struga, M; Wrzosek, M | 1 |
Boido, V; Collu, G; Delogu, I; Giliberti, G; La Colla, P; Loddo, R; Novelli, F; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M | 1 |
Briguglio, I; Carta, A; Corona, P; Farci, P; Fermeglia, M; Gavini, E; Giliberti, G; Giunchedi, P; Ibba, C; La Colla, P; Laurini, E; Loddo, R; Piras, S; Pricl, S; Sanna, G | 1 |
Atzori, EM; Briguglio, I; Carta, A; Collu, G; Corona, P; Delogu, I; Desideri, N; Fermeglia, M; Ibba, R; La Colla, P; Laurini, E; Loddo, R; Piras, S; Pricl, S | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Atzori, EM; Carta, A; Collu, G; Delogu, I; Desideri, N; Fioravanti, R; Loddo, R | 1 |
Lee, KH; Tzeng, CC; Wang, EC | 1 |
15 other study(ies) available for azauridine and acyclovir
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; Azo Compounds; Cell Line; Cell Survival; Diarrhea Viruses, Bovine Viral; DNA Viruses; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Respiratory Syncytial Viruses; RNA Viruses; RNA-Dependent RNA Polymerase; Structure-Activity Relationship; Triazenes; Viral Core Proteins | 2009 |
Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives.
Topics: Animals; Antiviral Agents; Benzimidazoles; Cell Line; Chlorocebus aethiops; Cricetinae; DNA Viruses; Humans; RNA Viruses; Small Molecule Libraries; Structure-Activity Relationship; Vero Cells | 2010 |
Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-dependent RNA polymerase inhibitors.
Topics: Antiviral Agents; Enzyme Inhibitors; Flaviviridae; Humans; Molecular Structure; Quinolines; RNA-Dependent RNA Polymerase; Structure-Activity Relationship | 2011 |
5-acetyl-2-arylbenzimidazoles as antiviral agents. Part 4.
Topics: Animals; Antiviral Agents; Benzimidazoles; Cattle; Cell Line; Cricetinae; Drug Design; Viruses | 2012 |
Synthesis and antiviral activity of new phenylimidazopyridines and N-benzylidenequinolinamines derived by molecular simplification of phenylimidazo[4,5-g]quinolines.
Topics: Aminoquinolines; Animals; Antiviral Agents; Cattle; Cell Line; Cell Survival; DNA Viruses; Dogs; Dose-Response Relationship, Drug; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Pyridines; RNA Viruses; Structure-Activity Relationship | 2014 |
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents.
Topics: Animals; Antiviral Agents; Benzimidazoles; Cattle; Cell Line; Cell Proliferation; Cell Survival; Chlorocebus aethiops; Cricetinae; Dose-Response Relationship, Drug; Enterovirus; Humans; Microbial Sensitivity Tests; Molecular Structure; Poliovirus; Respiratory Syncytial Viruses; Structure-Activity Relationship; Vero Cells; Virus Replication | 2014 |
N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: A novel class of anti-RSV agents.
Topics: Aniline Compounds; Antiviral Agents; Cell Line; Humans; Pyrazoles; Respiratory Syncytial Viruses; Virus Replication | 2015 |
Synthesis, cytotoxicity and antimicrobial activity of thiourea derivatives incorporating 3-(trifluoromethyl)phenyl moiety.
Topics: Aniline Compounds; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cell Line; Cell Proliferation; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Fungi; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiourea; Topoisomerase Inhibitors | 2015 |
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cricetinae; DNA Viruses; Dogs; Enterovirus B, Human; Humans; RNA Viruses; Structure-Activity Relationship; Triazoles; Virus Replication | 2015 |
Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives.
Topics: Antiviral Agents; DNA Viruses; Dose-Response Relationship, Drug; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Quinolines; Quinoxalines; RNA Viruses; Structure-Activity Relationship | 2015 |
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems.
Topics: Animals; Antiviral Agents; Binding Sites; Bovine Virus Diarrhea-Mucosal Disease; Cattle; Diarrhea Viruses, Bovine Viral; Hydrogen Bonding; Models, Molecular; Polycyclic Aromatic Hydrocarbons; RNA-Dependent RNA Polymerase | 2016 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation.
Topics: Animals; Antiviral Agents; Cattle; Cell Line; Cell Survival; Cricetinae; Dose-Response Relationship, Drug; Drug Design; Haplorhini; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Structure-Activity Relationship; Virus Replication; Yellow fever virus | 2017 |
Synthesis of 1-(2-hydroxyethoxymethyl)6-azauracil and its analogues--potential antiviral agents.
Topics: Acyclovir; Antiviral Agents; Azauridine; Uracil | 1985 |